ONCOLOGY INSTITUTE INC (TOI) — insider trading
Health Care · NASDAQ
ONCOLOGY INSTITUTE INC (TOI) has 40 reported SEC Form 4 insider transactions in our data, including 9 open-market purchases and 7 open-market sales among the most recent 40 (latest 2026-08-21).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Hively Brad | Director | Open-market sale | 298,853 | $6.51 | $1.95M | Form 4 |
| 2026-08-14 | Chernett Jorey | 10% owner | Open-market purchase | 12,000 | $6.54 | $78.5K | Form 4 |
| 2026-08-13 | Chernett Jorey | 10% owner | Open-market sale (derivative) | 100 | $6.24 | $624 | Form 4 |
| 2026-07-27 | Johnson Karen Marie | Director | Grant / award / vesting | 31,124 | — | $0 | Form 4 |
| 2026-07-27 | Hively Brad | Director | Grant / award / vesting | 27,108 | — | $0 | Form 4 |
| 2026-07-27 | TZOUMAKAS KIMBERLY JO | Director | Grant / award / vesting | 29,116 | — | $0 | Form 4 |
| 2026-07-27 | STOLPER MARK | Director | Grant / award / vesting | 31,124 | — | $0 | Form 4 |
| 2026-07-27 | Pacala Mark L | Director | Grant / award / vesting | 30,120 | — | $0 | Form 4 |
| 2026-07-27 | McGeorge Anne | Director | Grant / award / vesting | 41,165 | — | $0 | Form 4 |
| 2026-07-27 | Kaushal Mohit | Director | Grant / award / vesting | 33,133 | — | $0 | Form 4 |
| 2026-07-21 | Chernett Jorey | 10% owner | Open-market purchase | 18,000 | $5.27 | $94.9K | Form 4 |
| 2026-07-14 | Podnos Yale | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 5,478 | $2.00 | $11.0K | Form 4 |
| 2026-07-14 | Podnos Yale | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 17,974 | $1.87 | $33.6K | Form 4 |
| 2026-07-14 | Podnos Yale | Officer (Chief Medical Officer) | Open-market sale | 5,478 | $6.35 | $34.8K | Form 4 |
| 2026-07-14 | Podnos Yale | Officer (Chief Medical Officer) | Option exercise / conversion | 5,478 | $2.00 | $11.0K | Form 4 |
| 2026-07-14 | Podnos Yale | Officer (Chief Medical Officer) | Open-market sale | 17,974 | $6.43 | $115.6K | Form 4 |
| 2026-07-14 | Podnos Yale | Officer (Chief Medical Officer) | Option exercise / conversion | 17,974 | $1.87 | $33.6K | Form 4 |
| 2026-07-10 | Chernett Jorey | 10% owner | Open-market purchase | 15,000 | $5.85 | $87.8K | Form 4 |
| 2026-07-07 | STOLPER MARK | Director | Grant / award / vesting | 25,833 | — | $0 | Form 4 |
| 2026-07-07 | TZOUMAKAS KIMBERLY JO | Director | Grant / award / vesting | 17,185 | — | $0 | Form 4 |
| 2026-06-23 | Chernett Jorey | 10% owner | Open-market purchase | 18,000 | $5.02 | $90.4K | Form 4 |
| 2026-06-08 | Podnos Yale | Officer (Chief Medical Officer) | Open-market sale | 23,451 | $5.38 | $126.1K | Form 4 |
| 2026-06-04 | Chernett Jorey | 10% owner | Open-market purchase | 12,000 | $4.75 | $57.0K | Form 4 |
| 2026-05-21 | Carter Robert Ross | Officer (Chief Financial Officer) | Other acquisition or disposition | 1,604 | $4.47 | $7.2K | Form 4 |
| 2026-05-21 | Virnich Daniel | Officer (Chief Executive Officer) | Other acquisition or disposition | 23,058 | $4.47 | $103.1K | Form 4 |
| 2026-05-21 | Podnos Yale | Officer (Chief Medical Officer) | Other acquisition or disposition | 1,805 | $4.47 | $8.1K | Form 4 |
| 2026-05-20 | Chernett Jorey | 10% owner | Open-market purchase | 33,500 | $4.07 | $136.3K | Form 4 |
| 2026-05-19 | Chernett Jorey | 10% owner | Open-market purchase | 5,000 | $4.05 | $20.3K | Form 4 |
| 2026-05-19 | Chernett Jorey | 10% owner | Open-market purchase | 30,000 | $4.09 | $122.7K | Form 4 |
| 2026-04-16 | Kaushal Mohit | Director | Open-market sale | 38,433 | $3.50 | $134.5K | Form 4 |
| 2026-04-14 | Kaushal Mohit | Director | Open-market sale | 57,286 | $3.50 | $200.6K | Form 4 |
| 2026-04-09 | Chernett Jorey | 10% owner | Open-market purchase | 20,000 | $3.10 | $62.0K | Form 4 |
| 2026-03-27 | Virnich Daniel | Officer (Chief Executive Officer) | Other acquisition or disposition | 98,534 | $3.07 | $302.5K | Form 4 |
| 2026-03-27 | Virnich Daniel | Officer (Chief Executive Officer) | Grant / award / vesting | 670,608 | — | $0 | Form 4 |
| 2026-03-27 | Carter Robert Ross | Officer (Chief Financial Officer) | Other acquisition or disposition | 20,320 | $3.07 | $62.4K | Form 4 |
| 2026-03-27 | Carter Robert Ross | Officer (Chief Financial Officer) | Grant / award / vesting | 202,914 | — | $0 | Form 4 |
| 2026-03-27 | Podnos Yale | Officer (Chief Medical Officer) | Other acquisition or disposition | 16,173 | $3.07 | $49.7K | Form 4 |
| 2026-03-27 | Podnos Yale | Officer (Chief Medical Officer) | Grant / award / vesting | 66,446 | — | $0 | Form 4 |
| 2026-03-27 | England Kristin | Officer (Chief Administrative Officer) | Grant / award / vesting | 55,743 | — | $0 | Form 4 |
| 2026-03-27 | Langsam Jeffrey | Officer (Chief Clinical Officer) | Grant / award / vesting | 70,270 | — | $0 | Form 4 |
Ask the chat about TOI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ONCOLOGY INSTITUTE INC (TOI).
Last updated 2026-08-21 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.